May 20, 2020 / 2:52 PM / 18 days ago

BRIEF-Atossa Therapeutics Announces Successful In Vitro Testing Results Of Covid-19 Drug

May 20 (Reuters) - Atossa Therapeutics Inc:

* ATOSSA THERAPEUTICS ANNOUNCES SUCCESSFUL IN VITRO TESTING RESULTS OF COVID-19 DRUG: AT-H201 INHIBITS SARS-COV-2 INFECTIVITY OF VERO CELLS IN LABORATORY CULTURE

* ATOSSA THERAPEUTICS - PRELIMINARY STUDY RESULTS SHOW THAT AT-H201 INHIBITS SARS-COV-2 INFECTIVITY OF VERO CELLS IN A LABORATORY CULTURE

* ATOSSA THERAPEUTICS - FINDINGS FROM TESTING INCLUDE AT-H201 COMPONENTS INHIBITED SARS-COV-2 FROM INFECTING VERO CELLS IN A LABORATORY CULTURE

* ATOSSA THERAPEUTICS - COMPONENTS OF AT-H201 WERE FOUND TO BE AT LEAST FOUR-TIMES MORE POTENT THAN REMDESIVIR

* ATOSSA THERAPEUTICS - COMPONENTS OF AT-H201 WERE FOUND TO BE AT LEAST TWENTY-TIMES MORE POTENT THAN HYDROXYCHLOROQUINE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below